RecruitingPhase 3NCT04374799
Heparin vs Placebo for Cardiac Catheterization
A Randomized Trial of Heparin vs Placebo in Patients Undergoing Cardiac Catheterization Via the Trans-radial Approach
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Enrollment
1,623 participants
Start Date
Oct 5, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
Patients undergoing cardiac catheterization will be randomized to 3 groups: no anticoagulant, low dose anticoagulant and high dose anticoagulant.
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- diagnostic cardiac catheterization; Small size sheath; patency of the ulno-palmar circulation
Exclusion Criteria1
- abnormal ulno-palmar circulation; Prior radial artery thrombosis; Prior surgery close to the access site; Emergent cardiac catheterization; History of HIT or allergy to heparin; Patients requiring anticoagulation
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGHeparin
two doses of heparin
DRUGPlacebos
placebo
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04374799
Related Trials
Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay
NCT062941191 location
BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)
NCT0482366326 locations
Cardiac Clearance vs G60 Hip Frailty Index
NCT074901841 location
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac Surgery
NCT070327921 location
One-year Patency Comparison Between Radial Artery and No-touch Saphenous Vein Grafts in Women Undergoing Isolated CABG
NCT061793291 location